BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 34343303)

  • 1. High-affinity ZnT8 Autoantibodies by Electrochemiluminescence Assay Improve Risk Prediction for Type 1 Diabetes.
    Jia X; He L; Miao D; Waugh K; Rasmussen CG; Dong F; Steck AK; Rewers M; Yu L
    J Clin Endocrinol Metab; 2021 Nov; 106(12):3455-3463. PubMed ID: 34343303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel triple mix radiobinding assay for the three ZnT8 (ZnT8-RWQ) autoantibody variants in children with newly diagnosed diabetes.
    Vaziri-Sani F; Delli AJ; Elding-Larsson H; Lindblad B; Carlsson A; Forsander G; Ivarsson SA; Ludvigsson J; Marcus C; Lernmark Å
    J Immunol Methods; 2011 Aug; 371(1-2):25-37. PubMed ID: 21708156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel, high-performance, low-volume, rapid luciferase immunoprecipitation system (LIPS) assay to detect autoantibodies to zinc transporter 8.
    Williams CL; Marzinotto I; Brigatti C; Gillespie KM; ; Lampasona V; Williams AJK; Long AE
    Clin Exp Immunol; 2024 Feb; 215(3):215-224. PubMed ID: 38150393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Throughput Multiplex Electrochemiluminescence Assay Applicable to General Population Screening for Type 1 Diabetes and Celiac Disease.
    He L; Jia X; Rasmussen CG; Waugh K; Miao D; Dong F; Frohnert B; Steck AK; Simmons KM; Rewers M; Yu L
    Diabetes Technol Ther; 2022 Jul; 24(7):502-509. PubMed ID: 35238620
    [No Abstract]   [Full Text] [Related]  

  • 5. Childhood screening for type 1 diabetes comparing automated multiplex Antibody Detection by Agglutination-PCR (ADAP) with single plex islet autoantibody radiobinding assays.
    Lind A; Freyhult E; de Jesus Cortez F; Ramelius A; Bennet R; Robinson PV; Seftel D; Gebhart D; Tandel D; Maziarz M; Larsson HE; Lundgren M; Carlsson A; Nilsson AL; Fex M; Törn C; Agardh D; Tsai CT; Lernmark Å;
    EBioMedicine; 2024 Jun; 104():105144. PubMed ID: 38723553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput multiplexed autoantibody detection to screen type 1 diabetes and multiple autoimmune diseases simultaneously.
    Gu Y; Zhao Z; Waugh K; Miao D; Jia X; Cheng J; Michels A; Rewers M; Yang T; Yu L
    EBioMedicine; 2019 Sep; 47():365-372. PubMed ID: 31447394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese.
    Yang L; Luo S; Huang G; Peng J; Li X; Yan X; Lin J; Wenzlau JM; Davidson HW; Hutton JC; Zhou Z
    Diabetes Metab Res Rev; 2010 Oct; 26(7):579-84. PubMed ID: 20842762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zinc transporter 8 (ZnT8) autoantibody epitope specificity and affinity examined with recombinant ZnT8 variant proteins in specific ZnT8R and ZnT8W autoantibody-positive type 1 diabetes patients.
    Skärstrand H; Krupinska E; Haataja TJ; Vaziri-Sani F; Lagerstedt JO; Lernmark Å
    Clin Exp Immunol; 2015 Feb; 179(2):220-9. PubMed ID: 25178386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of ZnT8 Antibody in Turkish Children and Adolescents with New Onset Type 1 Diabetes.
    Elmaoğulları S; Uçaktürk SA; Elbeg Ş; Döğer E; Tayfun M; Gürbüz F; Bideci A
    J Clin Res Pediatr Endocrinol; 2018 Jun; 10(2):108-112. PubMed ID: 28943512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zinc transporter 8 autoantibodies complement glutamic acid decarboxylase and insulinoma-associated antigen-2 autoantibodies in the identification and characterization of Japanese type 1 diabetes.
    Kawasaki E; Oikawa Y; Okada A; Kanatsuna N; Kawamura T; Kikuchi T; Terasaki J; Miura J; Ito Y; Hanafusa T
    J Diabetes Investig; 2020 Sep; 11(5):1181-1187. PubMed ID: 32175683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of ZnT8 autoantibodies in the diagnosis of autoimmune diabetes in a large French cohort.
    Garnier L; Marchand L; Benoit M; Nicolino M; Bendelac N; Wright C; Moulin P; Lombard C; Thivolet C; Fabien N
    Clin Chim Acta; 2018 Mar; 478():162-165. PubMed ID: 29288641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive autoantibodies to ZnT8 indicate elevated risk for additional autoimmune conditions in patients with Addison's disease.
    Fichna M; Rogowicz-Frontczak A; Żurawek M; Fichna P; Gryczyńska M; Zozulińska-Ziółkiewicz D; Ruchała M
    Endocrine; 2016 Jul; 53(1):249-57. PubMed ID: 26972575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel enzyme-linked immunosorbent assay for bivalent ZnT8 autoantibodies.
    Kawasaki E; Tanaka M; Miwa M; Abiru N; Kawakami A
    Acta Diabetol; 2014; 51(3):429-34. PubMed ID: 24292540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc transporter 8 autoantibodies in patients with type 1 diabetes from a multiethnic population and their first degree relatives.
    Araujo DB; Skärstrand H; Barone B; Dantas JR; Kupfer R; Zajdenverg L; Milech A; Vaziri-Sani F; Oliveira JE; Rodacki M
    Arq Bras Endocrinol Metabol; 2014 Oct; 58(7):737-43. PubMed ID: 25372583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of Zinc Transporter 8 Autoantibody in the Diagnosis of Type 1 Diabetes in Latin Americans.
    Gomes KF; Semzezem C; Batista R; Fukui RT; Santos AS; Correia MR; Passos-Bueno MR; Silva ME
    Sci Rep; 2017 Mar; 7(1):207. PubMed ID: 28303020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of Islet Autoantibodies During Prospective Follow-Up From Birth to Age 15 Years.
    Pöllänen PM; Ryhänen SJ; Toppari J; Ilonen J; Vähäsalo P; Veijola R; Siljander H; Knip M
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4638-51. PubMed ID: 32882033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Use of Electrochemiluminescence Assays to Predict Autoantibody and Glycemic Progression Toward Type 1 Diabetes in Individuals with Single Autoantibodies.
    Sosenko JM; Yu L; Skyler JS; Krischer JP; Gottlieb PA; Boulware D; Miao D; Palmer JP; Steck AK
    Diabetes Technol Ther; 2017 Mar; 19(3):183-187. PubMed ID: 28177779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects.
    Wenzlau JM; Walter M; Gardner TJ; Frisch LM; Yu L; Eisenbarth GS; Ziegler AG; Davidson HW; Hutton JC
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4712-9. PubMed ID: 20610599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zinc transporter 8 (ZnT8) autoantibody prevalence in black South African participants with type 1 diabetes.
    Bhola S; Cave EM; Bhana S; Crowther NJ; Padoa CJ
    BMC Endocr Disord; 2021 Jul; 21(1):151. PubMed ID: 34271898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Detection of Islet Autoantibodies for Clinical Diagnosis of Type 1 Diabetes in the Low-Prevalence Population.
    Qi Y; Chen S; Chen H; Chen Y; Shi Y; Qin Y; Zhang M; Yang T; Gu Y
    J Clin Endocrinol Metab; 2023 May; 108(6):e326-e333. PubMed ID: 36480302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.